LEADER 04045nam 2200661 a 450 001 9911020226903321 005 20200520144314.0 010 $a9786613679239 010 $a9781280768460 010 $a1280768460 010 $a9780470718902 010 $a0470718900 010 $a9780470716335 010 $a0470716339 035 $a(CKB)1000000000687634 035 $a(EBL)703736 035 $a(SSID)ssj0000715215 035 $a(PQKBManifestationID)11377556 035 $a(PQKBTitleCode)TC0000715215 035 $a(PQKBWorkID)10700730 035 $a(PQKB)11699119 035 $a(MiAaPQ)EBC703736 035 $a(OCoLC)264615374 035 $a(Perlego)2770783 035 $a(EXLCZ)991000000000687634 100 $a19800627d1954 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCiba Foundation symposium on leukmia research /$feditors for the Ciba Foundation, G.E.W. Wolstenholme and Margaret P. Cameron ; assisted by Joan Etherington 210 $aBoston $cLittle, Brown$d1954 215 $a1 online resource (336 p.) 225 1 $aNovartis Foundation Symposia ;$vv.878 300 $a"With 56 illustrations." 311 08$a9780470722336 311 08$a0470722339 320 $aIncludes bibliographical references and index. 327 $aLEUKEMIA RESEARCH; CONTENTS; Chairman's Opening Remarks; On leukemia research; Therapeutic correlation between mouse and human leukemia; The shortcomings of animal research in leukemia; Discussion; The concept of conditioned and autonomous neoplasms; Discussion; The method of quantitative determination of fowl leukemia virus; Studies on the endocellular distribution of the transmissible fowl leukemia virus; Discussion; Some experimental observations on a strain of transmissible aleukemic leukemia (RPL 12 lymphoid tumour); Discussion 327 $aTransmissible mouse leukemia: biological properties of the mouse leukemia agent Discussion; The phenomena of resistance and dependence in leukemic cells; Discussion; Leukemic forms of the Murray-Begg endothelioma; Discussion; Respective values of electron and phase-contrast microscopy in the study of the leukemic cell; Discussion; Induction of leukemia by ionizing irradiation; Discussion; Studies on the modification of radiation injury; Discussion; The role of bone marrow and spleen in induced and spontaneous lymphatic leukemia; Discussion 327 $aExperimental and clinical aspects of the action of various carboxylic acid derivatives in the aromatic nitrogen mustard series Clinical experience with Myleran therapy, especially in myeloid leukemia; Discussion; A new colchicine derivative (Demecolcin CIBA) as a cytostatic agent in myelogenous leukemia; Discussion; The effect of 1 : 3-bis (ethyleneimino sulphonyl) propane in animal tumours and human leukemia; Discussion; The growth-inhibiting action of mitotic poisons in experimental and human leukemias; Discussion; The designing of selective drugs; Discussion 327 $aGeneral Discussion-Where do we go from here? New ideas for research on leukemia 330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 410 0$aNovartis Foundation Symposia 606 $aLeukemia 615 0$aLeukemia. 676 $a616.15 701 $aWolstenholme$b G. E. W$g(Gordon Ethelbert Ward)$063039 701 $aCameron$b Margaret P$0290945 712 12$aSymposium on Leukaemia Research$f(1953 :$eCiba Foundation) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911020226903321 996 $aCiba Foundation symposium on leukmia research$94417624 997 $aUNINA